{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,5]],"date-time":"2026-09-05T05:27:05Z","timestamp":1788586025905,"version":"build-2803163510"},"reference-count":36,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2008,1,1]],"date-time":"2008-01-01T00:00:00Z","timestamp":1199145600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2013,8,22]],"date-time":"2013-08-22T00:00:00Z","timestamp":1377129600000},"content-version":"vor","delay-in-days":2060,"URL":"https:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["International Journal of Infectious Diseases"],"published-print":{"date-parts":[[2008,1]]},"DOI":"10.1016\/j.ijid.2007.04.015","type":"journal-article","created":{"date-parts":[[2007,7,24]],"date-time":"2007-07-24T11:10:46Z","timestamp":1185275446000},"page":"51-56","source":"Crossref","is-referenced-by-count":23,"title":["Risk factors and algorithms to identify hepatitis C, hepatitis B, and HIV among Georgian tuberculosis patients"],"prefix":"10.1016","volume":"12","author":[{"given":"Mark H.","family":"Kuniholm","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer","family":"Mark","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Malvina","family":"Aladashvili","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"N.","family":"Shubladze","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G.","family":"Khechinashvili","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tengiz","family":"Tsertsvadze","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlos","family":"del Rio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenrad E.","family":"Nelson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijid.2007.04.015_bib1","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1001\/jama.282.7.677","article-title":"Consensus statement. Global burden of tuberculosis: estimated incidence, prevalence, and mortality by country. WHO Global Surveillance and Monitoring Project","volume":"282","author":"Dye","year":"1999","journal-title":"JAMA"},{"key":"10.1016\/j.ijid.2007.04.015_bib2","doi-asserted-by":"crossref","first-page":"938","DOI":"10.1016\/S0140-6736(06)68384-0","article-title":"Global epidemiology of tuberculosis","volume":"367","author":"Dye","year":"2006","journal-title":"Lancet"},{"key":"10.1016\/j.ijid.2007.04.015_bib3","doi-asserted-by":"crossref","first-page":"1364","DOI":"10.1136\/bmj.38645.660093.68","article-title":"Cost effectiveness analysis of strategies for tuberculosis control in developing countries","volume":"331","author":"Baltussen","year":"2005","journal-title":"BMJ"},{"key":"10.1016\/j.ijid.2007.04.015_bib4","doi-asserted-by":"crossref","first-page":"952","DOI":"10.1016\/S0140-6736(06)68392-X","article-title":"WHO's new Stop TB Strategy","volume":"367","author":"Raviglione","year":"2006","journal-title":"Lancet"},{"key":"10.1016\/j.ijid.2007.04.015_bib5","doi-asserted-by":"crossref","first-page":"922","DOI":"10.1164\/rccm.200512-1953OC","article-title":"Weekly rifapentine\/isoniazid or daily rifampin\/pyrazinamide for latent tuberculosis in household contacts","volume":"173","author":"Schechter","year":"2006","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.ijid.2007.04.015_bib6","doi-asserted-by":"crossref","first-page":"e158","DOI":"10.1086\/375072","article-title":"Severe hepatotoxicity associated with rifampin\u2013pyrazinamide preventative therapy requiring transplantation in an individual at low risk for hepatotoxicity","volume":"36","author":"Kunimoto","year":"2003","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.ijid.2007.04.015_bib7","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1086\/422645","article-title":"Hepatotoxicity of rifampin\u2013pyrazinamide and isoniazid preventive therapy and tuberculosis treatment","volume":"39","author":"van Hest","year":"2004","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.ijid.2007.04.015_bib8","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1517\/14740338.5.2.231","article-title":"Adverse reactions to first-line antituberculosis drugs","volume":"5","author":"Forget","year":"2006","journal-title":"Expert Opin Drug Saf"},{"key":"10.1016\/j.ijid.2007.04.015_bib9","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1183\/09031936.05.00006205","article-title":"High hepatotoxicity of pyrazinamide and ethambutol for treatment of latent tuberculosis","volume":"26","author":"Younossian","year":"2005","journal-title":"Eur Respir J"},{"key":"10.1016\/j.ijid.2007.04.015_bib10","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1378\/chest.128.1.116","article-title":"Isoniazid hepatotoxicity associated with treatment of latent tuberculosis infection: a 7-year evaluation from a public health tuberculosis clinic","volume":"128","author":"Fountain","year":"2005","journal-title":"Chest"},{"key":"10.1016\/j.ijid.2007.04.015_bib11","doi-asserted-by":"crossref","first-page":"1296","DOI":"10.1378\/chest.127.4.1296","article-title":"Adverse events and treatment completion for latent tuberculosis in jail inmates and homeless persons","volume":"127","author":"Lobato","year":"2005","journal-title":"Chest"},{"key":"10.1016\/j.ijid.2007.04.015_bib12","doi-asserted-by":"crossref","first-page":"916","DOI":"10.1164\/rccm.2108091","article-title":"Evaluation of clinical and immunogenetic risk factors for the development of hepatotoxicity during antituberculosis treatment","volume":"166","author":"Sharma","year":"2002","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.ijid.2007.04.015_bib13","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1136\/thx.51.2.132","article-title":"Risk factors for hepatotoxicity from antituberculosis drugs: a case\u2013control study","volume":"51","author":"Pande","year":"1996","journal-title":"Thorax"},{"key":"10.1016\/j.ijid.2007.04.015_bib14","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1086\/345906","article-title":"Isoniazid hepatotoxicity among drug users: the role of hepatitis C","volume":"36","author":"Fernandez-Villar","year":"2003","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.ijid.2007.04.015_bib15","doi-asserted-by":"crossref","first-page":"1687","DOI":"10.1086\/323896","article-title":"Isoniazid preventive therapy, hepatitis C virus infection, and hepatotoxicity among injection drug users infected with Mycobacterium tuberculosis","volume":"33","author":"Sadaphal","year":"2001","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.ijid.2007.04.015_bib16","doi-asserted-by":"crossref","first-page":"1871","DOI":"10.1164\/ajrccm.157.6.9711039","article-title":"Antituberculosis drug-induced hepatotoxicity. The role of hepatitis C virus and the human immunodeficiency virus","volume":"157","author":"Ungo","year":"1998","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.ijid.2007.04.015_bib17","doi-asserted-by":"crossref","first-page":"2518","DOI":"10.3748\/wjg.v11.i16.2518","article-title":"Effect of anti-tuberculosis therapy on liver function of pulmonary tuberculosis patients infected with hepatitis B virus","volume":"11","author":"Pan","year":"2005","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.ijid.2007.04.015_bib18","doi-asserted-by":"crossref","first-page":"1745","DOI":"10.1111\/j.1440-1746.2005.04048.x","article-title":"Monitoring and management of antituberculosis drug induced hepatotoxicity","volume":"20","author":"Agal","year":"2005","journal-title":"J Gastroenterol Hepatol"},{"key":"10.1016\/j.ijid.2007.04.015_bib19","first-page":"534","article-title":"Severe hepatotoxicity due to anti-tuberculosis drugs in Spain","volume":"9","author":"Tost","year":"2005","journal-title":"Int J Tuberc Lung Dis"},{"key":"10.1016\/j.ijid.2007.04.015_bib20","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1086\/422724","article-title":"Hepatotoxicity of rifampin and pyrazinamide in the treatment of latent tuberculosis infection in HIV-infected persons: is it different than in HIV-uninfected persons?","volume":"39","author":"Gordin","year":"2004","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.ijid.2007.04.015_bib21","doi-asserted-by":"crossref","first-page":"1834","DOI":"10.1016\/j.rmed.2006.01.014","article-title":"Side effects due to primary antituberculosis drugs during the initial phase of therapy in 1149 hospitalized patients for tuberculosis","volume":"10","author":"Gulbay","year":"2006","journal-title":"Respir Med"},{"key":"10.1016\/j.ijid.2007.04.015_bib22","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1185\/030079906X80387","article-title":"Assessment of age-related isoniazid hepatotoxicity during treatment of latent tuberculosis infection","volume":"22","author":"Aziz","year":"2006","journal-title":"Curr Med Res Opin"},{"key":"10.1016\/j.ijid.2007.04.015_bib23","doi-asserted-by":"crossref","first-page":"1304","DOI":"10.1378\/chest.127.4.1304","article-title":"Inactive hepatitis B surface antigen carrier state and hepatotoxicity during antituberculosis chemotherapy","volume":"127","author":"Lee","year":"2005","journal-title":"Chest"},{"key":"10.1016\/j.ijid.2007.04.015_bib24","doi-asserted-by":"crossref","first-page":"2767","DOI":"10.1001\/jama.293.22.2767","article-title":"Evolution of tuberculosis control and prospects for reducing tuberculosis incidence, prevalence, and deaths globally","volume":"293","author":"Dye","year":"2005","journal-title":"JAMA"},{"key":"10.1016\/j.ijid.2007.04.015_bib25","first-page":"396","article-title":"High prevalence of hepatitis C virus but not HIV co-infection among patients with tuberculosis in Georgia","volume":"10","author":"Richards","year":"2006","journal-title":"Int J Tuberc Lung Dis"},{"key":"10.1016\/j.ijid.2007.04.015_bib26","first-page":"164","article-title":"Risk for tuberculosis infection among internally displaced persons in the Republic of Georgia","volume":"5","author":"Weinstock","year":"2001","journal-title":"Int J Tuberc Lung Dis"},{"key":"10.1016\/j.ijid.2007.04.015_bib27","first-page":"1104","article-title":"Pulmonary tuberculosis in prisons of the ex-USSR state of Georgia: results of a nation-wide prevalence survey among sentenced inmates","volume":"4","author":"Aerts","year":"2000","journal-title":"Int J Tuberc Lung Dis"},{"key":"10.1016\/j.ijid.2007.04.015_bib28","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1258\/0956462052932683","article-title":"The emerging HIV\/AIDS epidemic in Georgia","volume":"16","author":"Tkeshelashvili-Kessler","year":"2005","journal-title":"Int J STD AIDS"},{"key":"10.1016\/j.ijid.2007.04.015_bib29","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1023\/A:1015566132757","article-title":"Prevalence of hepatitis B, hepatitis C, syphilis and HIV in Georgian blood donors","volume":"17","author":"Butsashvili","year":"2001","journal-title":"Eur J Epidemiol"},{"key":"10.1016\/j.ijid.2007.04.015_bib30","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1023\/B:EJEP.0000032352.29173.78","article-title":"Risk factors for hepatitis C virus infection among blood donors in Georgia","volume":"19","author":"Zaller","year":"2004","journal-title":"Eur J Epidemiol"},{"key":"10.1016\/j.ijid.2007.04.015_bib31","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1007\/s11524-006-9032-y","article-title":"Prevalence of hepatitis C, HIV, and risk behaviors for blood-borne infections: a population-based survey of the adult population of T\u2019bilisi, Republic of Georgia","volume":"83","author":"Stvilia","year":"2006","journal-title":"J Urban Health"},{"key":"10.1016\/j.ijid.2007.04.015_bib32","unstructured":"World Health Organization. Global TB database. Georgia; 2005."},{"key":"10.1016\/j.ijid.2007.04.015_bib33","doi-asserted-by":"crossref","first-page":"501","DOI":"10.3201\/eid1103.040903","article-title":"Mycobacterium tuberculosis drug resistance, Abkhazia","volume":"11","author":"Pardini","year":"2005","journal-title":"Emerg Infect Dis"},{"key":"10.1016\/j.ijid.2007.04.015_bib34","first-page":"394","article-title":"Tuberculosis control in the Caucasus: successes and constraints in DOTS implementation","volume":"3","author":"Zalesky","year":"1999","journal-title":"Int J Tuberc Lung Dis"},{"key":"10.1016\/j.ijid.2007.04.015_bib35","first-page":"1027","article-title":"Barriers to completion of tuberculosis treatment among prisoners and former prisoners in St. Petersburg, Russia","volume":"9","author":"Fry","year":"2005","journal-title":"Int J Tuberc Lung Dis"},{"key":"10.1016\/j.ijid.2007.04.015_bib36","doi-asserted-by":"crossref","first-page":"S132","DOI":"10.1016\/j.jhep.2005.11.027","article-title":"Hepatotoxicity of antiretrovirals: incidence, mechanisms and management","volume":"44","author":"N\u00fa\u00f1ez","year":"2006","journal-title":"J Hepatol"}],"container-title":["International Journal of Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1201971207001014?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1201971207001014?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,1,5]],"date-time":"2019-01-05T22:00:04Z","timestamp":1546725604000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1201971207001014"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,1]]},"references-count":36,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2008,1]]}},"alternative-id":["S1201971207001014"],"URL":"https:\/\/doi.org\/10.1016\/j.ijid.2007.04.015","relation":{},"ISSN":["1201-9712"],"issn-type":[{"value":"1201-9712","type":"print"}],"subject":[],"published":{"date-parts":[[2008,1]]}}}